Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-016-1581-0
Published Online: 2016-09-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Howard, Dena R.
Munir, Talha
Hockaday, Anna
Rawstron, Andy C.
Collett, Laura
Oughton, Jamie B.
Allsup, David
Bloor, Adrian
Phillips, David
Hillmen, Peter
Funding for this research was provided by:
GlaxoSmithKline
License valid from 2016-09-20